Simply Oncology

Episode 99: Fundamentals- Early stage melanoma with Dr Toby Talbot (Part 2)

John McGrane & Michael Rowe

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 23:21

Send us Fan Mail

Welcome back for Part 2 of our Early Melanoma series with Dr Toby Talbot.

We dive in to the potential side effects of treatment and how this affects decisions about adjuvant treatment.

We hear about adjuvant BRAF targeted therapy, with more side effects but temporary ones.

We look at the future with the NADINA trial for neoadjuvant immunotherapy in high risk clinical stage III disease, the emerging role of cancer vaccines, and biomarkers to try and find the right treatment for the right patient.

Tour de force as always. Keep an eye out for upcoming podcasts on the treatment of advanced/metastatic melanoma.